Results 11 to 20 of about 11,403 (144)

Post-treatment Lyme disease symptoms score: Developing a new tool for research. [PDF]

open access: yesPLoS ONE, 2019
Some patients have residual non-specific symptoms after therapy for Lyme disease, referred to as post-treatment Lyme disease symptoms or syndrome, depending on whether there is functional impairment. A standardized test battery was used to characterize a
Siu P Turk   +11 more
doaj   +5 more sources

Association of small fiber neuropathy and post treatment Lyme disease syndrome. [PDF]

open access: yesPLoS ONE, 2019
ObjectivesTo examine whether post-treatment Lyme disease syndrome (PTLDS) defined by fatigue, cognitive complaints and widespread pain following the treatment of Lyme disease is associated with small fiber neuropathy (SFN) manifesting as autonomic and ...
Peter Novak   +4 more
doaj   +5 more sources

Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome [PDF]

open access: yesInternational Medical Case Reports Journal, 2017
Ashraf F Hanna, Bishoy Abraham, Andrew Hanna, Adam J Smith Department of Pain Management, Florida Spine Institute, Clearwater, FL, USA Abstract: Post-treatment Lyme disease syndrome (PTLDS) is a pain disorder for which there remains no ...
Hanna AF, Abraham B, Hanna A, Smith AJ
doaj   +5 more sources

The Persistent Lyme Disease: “True Chronic Lyme Disease” rather than “Post-treatment Lyme Disease Syndrome”

open access: yesJournal of Global Infectious Diseases, 2018
Alexis Lacout   +3 more
doaj   +4 more sources

Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study. [PDF]

open access: yesInternational Journal of Infectious Diseases, 2022
Purpose: Post-treatment Lyme disease (PTLD) is characterized by patient-reported symptoms after treatment for Borrelia burgdorferi infection. The primary aim of this study was to assess whether participants with a history of Lyme disease (LD) would be ...
John N. Aucott   +5 more
doaj   +3 more sources

Pilot study of psilocybin in patients with post-treatment lyme disease [PDF]

open access: yesScientific Reports
Lyme disease, caused by the bacterium Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Although antibiotics effectively treat most cases, an estimated 10–20% of patients develop post-treatment Lyme disease ...
Albert Garcia-Romeu   +9 more
doaj   +2 more sources

Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options. [PDF]

open access: yesCureus, 2023
Lyme disease and its treatment implications have become an ever-increasing area of concern within the United States related to the markedly increased prevalence of infection within the last two decades. The presentation, pathophysiology, and epidemiology of Lyme disease have been well studied, and thus treatments for this disease are widely available ...
Talbot NC   +11 more
europepmc   +3 more sources

Gene set predictor for post-treatment Lyme disease. [PDF]

open access: yesCell Rep Med, 2022
Lyme disease (LD) is tick-borne disease whose post-treatment sequelae are not well understood. For this study, we enrolled 152 individuals with symptoms of post-treatment LD (PTLD) to profile their peripheral blood mononuclear cells (PBMCs) with RNA sequencing (RNA-seq).
Clarke DJB   +5 more
europepmc   +3 more sources

Update of the Swiss guidelines on post-treatment Lyme disease syndrome

open access: yesSwiss Medical Weekly, 2016
Lyme borreliosis is caused by Borrelia burgdorferi sensu lato infection, which responds well to antibiotic therapy in the overwhelming majority of cases.
Johannes Nemeth   +14 more
doaj   +8 more sources

Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET [PDF]

open access: yesJournal of Neuroinflammation, 2018
The pathophysiology of post-treatment Lyme disease syndrome (PTLDS) may be linked to overactive immunity including aberrant activity of the brain’s resident immune cells, microglia.
Jennifer M. Coughlin   +16 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy